HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR

摘要

Provided are novel heterocyclic compounds useful as anti-cancer drugs by suppressing protein kinase activities of growth factor receptors such as c-Met, pharmaceutical compositions containing the same, and methods for using the compound. Also, the pharmaceutical composition containing the compound is useful in treating diseases other than cancer, related to signal transduction pathways operated through a receptors of growth factors and antineo-vascularization, for example, c-Met.